ATM c.7570G>C is a high-risk allele for breast cancer

dc.contributor.authorKankuri-Tammilehto Minna
dc.contributor.authorTerväsmäki Anna
dc.contributor.authorKraatari-Tiri Minna
dc.contributor.authorRahikkala Elisa
dc.contributor.authorPylkäs Katri
dc.contributor.authorKuismin Outi
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id176812533
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/176812533
dc.date.accessioned2022-11-29T15:53:16Z
dc.date.available2022-11-29T15:53:16Z
dc.description.abstractATM is generally described as a moderate-risk breast cancer susceptibility gene. However, some of ATM variants might encounter higher risk. ATM c.7570G>C, p.Ala2524Pro, (rs769142993) is a pathogenic Finnish founder variant causative for recessively inherited ataxia-telangiectasia. At cellular level, it has been reported to have a dominant-negative effect. ATM c.7570G>C has recurrently been described in Finnish breast cancer families and unselected case cohorts collected from different parts of the country, but the rarity of the allele (MAF 0.0002772 in Finns) and lack of confirming segregation analyses have prevented any conclusive risk estimates. Here, we describe seven families from genetic counseling units with ATM c.7570G>C variant showing co-segregation with breast cancer. Further analysis of the unselected breast cancer cohort from Northern Finland (n = 1822), a geographical region previously indicated to have enrichment of the variant, demonstrated that c.7570G>C significantly associates with breast cancer, and the risk is estimated as high (odds ratio [OR] = 8.5, 95% confidence interval [CI] = 1.04-62.46, P = .018). Altogether, these results place ATM c.7570G>C variant among the high-risk alleles for breast cancer, which should be taken into consideration in genetic counseling.
dc.identifier.jour-issn0020-7136
dc.identifier.olddbid190306
dc.identifier.oldhandle10024/173397
dc.identifier.urihttps://www.utupub.fi/handle/11111/34762
dc.identifier.urlhttps://doi.org/10.1002/ijc.34305
dc.identifier.urnURN:NBN:fi-fe2022112968071
dc.language.isoen
dc.okm.affiliatedauthorKankuri-Tammilehto, Minna
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWILEY
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1002/ijc.34305
dc.relation.ispartofjournalInternational Journal of Cancer
dc.source.identifierhttps://www.utupub.fi/handle/10024/173397
dc.titleATM c.7570G>C is a high-risk allele for breast cancer
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Intl Journal of Cancer - 2022 - Kankuri‐Tammilehto - ATM c 7570G C is a high‐risk allele for breast cancer.pdf
Size:
540.61 KB
Format:
Adobe Portable Document Format